No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
PER Percheron Therapeutics Ltd
- 0.007
- 0.0000.00%
20min DelayMarket Closed Dec 24 14:10 AET
7.61MMarket Cap-0.50P/E (Static)
0.008High0.007Low10.33MVolume0.007Open0.007Pre Close72.34KTurnover0.14052wk High1.16%Turnover Ratio1.09BShares0.00552wk Low-0.014EPS TTM6.24MFloat Cap0.140Historical HighLossP/E (Static)891.65MShs Float0.005Historical Low-0.014EPS LYR14.29%Amplitude--Dividend TTM0.78P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Percheron Therapeutics Discontinues American Depository Receipt Facility, Uplists to OTCQB
Just the Facts: Percheron Hits Milestone in Duchenne Drug Trial | ASX:PER, OTC:PERCF
Percheron Therapeutics Advances Phase 2b Muscular Dystrophy Clinical Trial; Shares Down 3%
Percheron Therapeutics Price Target Cut 7% to A$0.25/Share by Wilsons
Percheron Therapeutics to Raise AU$13 Million via Share Placement; Shares Slump 35%
Percheron Therapeutics Ltd: Percheron Receives $2.35 million R&D Tax Incentive Rebate
Heat List
AU
Overall
Symbol
Price
% Chg
No Data